Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.
Colossal Biosciences has expanded its efforts to save animals currently on the brink with its acquisition of the cloning ...
How they’re doing it: The new company, called Preventive, is being formed to research so-called “heritable genome editing,” ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...
Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...
Researchers in Mexico are turning their focus towards a revolutionary technique to enhance crop resilience. According to News Arena India, the International Maize and Wheat Improvement Center, also ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback